Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer [Phase 3]
Phase 3 trial of tasquinimod in Asian chemo-naïve patients with metastatic castration-resistant prostate cancer was terminated; results post…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients [Phase 1, Phase 2]
Phase 1/2A study of TRC253, an androgen receptor antagonist, in metastatic castration-resistant prostate cancer completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the effects of Coenzyme A combined with Abiraterone in patients with castration-resistant prostate cance…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer [Phase 3]
Phase III study evaluating DCVAC/PCa added to standard chemotherapy for metastatic castration-resistant prostate cancer has completed with r…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy [Phase 2]
Phase 2 trial of Lu-177 PSMA-directed endoradiotherapy for metastatic castration-resistant prostate cancer was terminated; results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Oral Calcitriol With Ketoconazole in CRPC [Phase 2]
Phase 2 clinical trial evaluating oral calcitriol with ketoconazole in castration-resistant prostate cancer; study terminated with results p…
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy [Phase 2]
This Phase 2 clinical trial update investigates genetic and molecular factors associated with response to enzalutamide in prostate cancer, i…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer [NA]
Clinical trial update on a home-based exercise intervention for patients with metastatic castration-resistant prostate cancer undergoing and…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of enzalutamide and cabazitaxel for metastatic castration-resistant prostate cancer; results were…
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide [Phase 4]
Phase 4 trial evaluating whether Enzalutamide increases seizure risk in metastatic castration-resistant prostate cancer; results have been p…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating GS-5829 (alobresib) as a single agent and with enzalutamide in metastatic castration-resistant prostate cancer; s…
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer. [Phase 2]
Phase 2 trial update evaluating abiraterone acetate with docetaxel after progression to abiraterone in metastatic castration-resistant prost…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating abiraterone acetate and prednisone with or without veliparib in metastatic castration-resistant prostate cancer has…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
Phase 1 dose-finding study of GSK2636771 in combination with enzalutamide in metastatic castration-resistant prostate cancer completed.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating selegiline in combination with docetaxel for metastatic castration-resistant prostate cancer; current stat…
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) [Phase 3]
Phase 3 trial comparing Olaparib to enzalutamide or abiraterone in men with metastatic castration-resistant prostate cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer [Phase 2]
Phase II study evaluating higher-dose abiraterone acetate in castration-resistant prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Sequencing Abiraterone and Enzalutamide in mCRPC [Phase 2]
A Phase 2 trial update evaluating sequencing of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer has complete…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation [Phase 1, Phase 2]
Clinical trial update for SC10914 monotherapy in metastatic castration-resistant prostate cancer with g/s BRCA mutation, covering Phase 1 an…
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial update for pembrolizumab in metastatic castration-resistant prostate cancer (mCRPC) with unclear status.
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer [Phase 3]
Phase 3 trial evaluating enzalutamide with or without abiraterone and prednisone in castration-resistant metastatic prostate cancer; status …
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 PET/CT imaging study in patients receiving enzalutamide for castration-resistant prostate cancer with bone metastases has completed …
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy [Phase 2]
Phase 2 study of abiraterone acetate in chemo-naive metastatic castration-resistant prostate cancer patients with prior diethylstilbestrol e…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA [Phase 2]
Phase 2 clinical trial evaluating biomarkers of androgen response and resistance in patients with castration-resistant prostate cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: 177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for 177Lu-PSMA-I&T radioligand therapy in metastatic castration-resistant prostate cancer.